We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Surgical Robot with Humanoid-Shaped Arms Replicates Surgeon’s Motions

By HospiMedica International staff writers
Posted on 29 Jun 2022

Robot-assisted surgery is regarded as a must-have by doctors and patients everywhere, due to advances in precision and dexterity, superior control, device multi-functionality, ergonomics, and avoidance of hand tremor and fulcrum effects. More...

Yet even today’s gold-standard solutions remain a mixed offering. Despite being mainstays of minimally-invasive surgery, many robotic procedures require multi-port access and provide limited maneuverability to the surgeon – who is furthermore required to master a massively complex, unintuitive user interface. Due to these and other limitations, these procedures have not been proven to substantially reduce complication rates. Now, the first and only FDA-authorized surgical robot with humanoid-shaped arms designed to replicate the motions and capabilities of a surgeon’s arms provides outstanding surgical and ergonomics capabilities while keeping cost and footprint to a minimum.

The Hominis Surgical System for robotic-assisted transvaginal hysterectomy from Memic Innovative Surgery Ltd. (Tel Aviv, Israel) is the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide high dexterity and unprecedented articulation. The Hominis System is designed to replicate the motions and capabilities of a surgeon's arms. Multiple instruments can be introduced into the body through a single portal and the unprecedented articulation offers optimal access and working angles.

Hominis requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery. Hominis was granted de novo marketing authorization from the FDA in February 2021. Two hospitals have successfully completed the first U.S. patient procedures using the Hominis Surgical System for robotic-assisted transvaginal hysterectomy.

"It is very encouraging to see the first two U.S. commercial sites actively performing benign gynecological procedures using our Hominis System and we are grateful for their support," said Dvir Cohen, president and chief executive officer of Memic. "Hominis is well positioned as a disruptive technology that will transform the way surgeons perform minimally invasive robotic-assisted procedures."

Related Links:
Memic Innovative Surgery Ltd.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.